Schedule 13G ownership disclosure

Edgewise Therapeutics Inc

Security class unavailable · CUSIP: 28036F105

Event date: 2022-09-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,493,194
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-22-000530
Form type
SC 13G
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
Sep 26, 2022
Reporting period
Sep 14, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub